---
title: "MULLEN MICHAEL JAMES — Ownership Dossier"
canonical: https://whiteintel.dev/entity/290cf728-e65f-5e51-8e6e-79b59751d62a
json: https://whiteintel.dev/api/public/dossier/290cf728-e65f-5e51-8e6e-79b59751d62a
identifier: sec:0001294092
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MULLEN MICHAEL JAMES

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001294092`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/290cf728-e65f-5e51-8e6e-79b59751d62a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/290cf728-e65f-5e51-8e6e-79b59751d62a  

## Ownership & control

### Holdings / subsidiaries

- **ALSERES PHARMACEUTICALS INC /DE** (director) — https://whiteintel.dev/entity/afbe6367-df2f-58b9-8f26-8cbd10f79fdc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MULLEN MICHAEL JAMES**. Human view: https://whiteintel.dev/entity/290cf728-e65f-5e51-8e6e-79b59751d62a · Structured JSON: https://whiteintel.dev/api/public/dossier/290cf728-e65f-5e51-8e6e-79b59751d62a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._